These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy. Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J. Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611 [Abstract] [Full Text] [Related]
13. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases]. He YF, Zhang YJ, Li YH, Lin TY, Xia YF, Lu TX, Huang HQ, Jiang WQ, Xian CG, He YJ, Guan ZZ. Ai Zheng; 2006 Dec 10; 25(12):1538-42. PubMed ID: 17166382 [Abstract] [Full Text] [Related]
16. Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Huang MJ, Jiang Y, Liu WP, Li ZP, Li M, Zhou L, Xu Y, Yu CH, Li Q, Peng F, Liu JY, Luo F, Lu Y. Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):166-74. PubMed ID: 17919841 [Abstract] [Full Text] [Related]
17. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. Li YX, Yao B, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Zhou LQ, He XH, Lu N, Yu ZH. J Clin Oncol; 2006 Jan 01; 24(1):181-9. PubMed ID: 16382127 [Abstract] [Full Text] [Related]